Back

Suppression of Fibulin 5 Attenuated Pulmonary Arterial Hypertension Associated with Congenital Heart Disease via Mitigating Pulmonary Arterial Smooth Muscle Cell Dysfunction

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Novel insights into vascular remodelling Hypertension, Pulmonary Hypertension ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Yicheng Yang

State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular D, Beijing (China)

5 More presentations in this session

Presentation thumbnail
Novel balloon catheter containing therapeutic mRNA with smart RNA switch alleviate restenosis after vascular injury
Doctor Y. Fu (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
ERBB4 activation prevents microvascular dysfunction in a large animal model of hypertensive heart disease
Doctor T. Bringmans (Mechelen, BE)
Abstract Slides Video
Presentation thumbnail
Impact of neonatal hyperoxia on the development of the coronary vascular bed: an experimental model for the study of cardiomyopathy associated with premature birth
Doctor P. Girault-Sotias (Montreal, CA)
Abstract Slides Video
Presentation thumbnail
Parathyroid hormone exacerbates pulmonary hypertension via parathyroid hormone receptors on pulmonary artery smooth muscle cells
Assistant Professor Y. Joki (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
The novel role of complement 3 in Wnt5a-mediated vascular smooth muscle cell calcification
Doctor I. Badi (Oxford, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Novel insights into vascular remodelling
Video

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources